In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Humana Inc.’s current price is 38.9% below a high-confidence fair value of $505.41, indicating potential undervaluation. Monte Carlo analysis shows significant upside with a median $625.21 and moderate downside risk (8.3%), but financial health scores highlight fair liquidity, profitability, and growth, signaling moderate operational risk. Elevated valuation volatility (62.76% CV) reflects uncertainty in future cash flows.